Related Experiment Video
Updated: Jul 20, 2026
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Extended cooperation in clinical studies through exchange of CDISC metadata between different study software
W Kuchinke1, S Wiegelmann, P Verplancke
1Coordination Center for Clinical Studies (KKSD), Heinrich Heine University, 40225 Duesseldorf, Germany. kuchinkw@uni-duesseldorf.de
Methods of Information in Medicine
|September 12, 2006
Summary
Metadata exchange between clinical study software systems is feasible using the ODM standard. This enables system-independent data transfer with minimal effort, facilitating collaboration across research centers.
Area of Science:
- Clinical research informatics
- Data standards in clinical trials
Background:
- Clinical study software systems often operate independently.
- Interoperability challenges hinder seamless data sharing and collaboration.
- Standardized metadata exchange is crucial for efficient clinical research.
Purpose of the Study:
- To assess the feasibility of transferring entire clinical studies between independent software solutions.
- To determine if software-independent metadata transfer is possible without programming.
- To evaluate the use of routinely used clinical research software for data exchange.
Main Methods:
- Utilized the ODM (CDISC) standard for study metadata transfer.
- Employed MACRO (InferMed) and XTrial (XClinical) study software.
- Used XML-Spy and ODM-Checker for validation and modification of ODM export files.
Main Results:
- Successfully demonstrated the technical feasibility of system-independent metadata exchange.
- Achieved interchange of study metadata between two systems with minimal expenditure.
- Required minor corrections and a vendor extension for a syntactically correct ODM file.
- XTrial correctly displayed the study and all data fields after modifications, though CRF appearance differed.
Conclusions:
- The ODM standard is suitable as an exchange format for clinical studies between different software.
- Enables new collaborative possibilities, such as joint creation of electronic protocols and CRFs.
- While ODM represents study data completely, it lacks information on CRF data field representation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:12Statistical Software for Data Analysis and Clinical Trials
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...